The National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) is the largest BRC outside the South East of England and the beating heart of translational research across Greater Manchester, Lancashire and South Cumbria, transforming scientific breakthroughs into diagnostic tests and life-saving treatments for patients.
Awarded £59.1 million (2022-27) – the largest single research award given by the NIHR to the city region – Manchester BRC brings together world-leading researchers based at The University of Manchester and six of the country’s foremost NHS Trusts, with a vision to drive health improvements and lasting change for all through creative, inclusive and proactive research that identifies and bridges gaps between new discoveries and individualised care.
Manchester BRC is driving forward pioneering research in the areas of cancer (prevention and early detection, advanced radiotherapy, precision medicine, living with and beyond cancer), inflammation (rheumatic and musculoskeletal disease, respiratory medicine, dermatology, integrative cardiovascular medicine), high-burden under-researched conditions (hearing health, mental health, rare conditions) and disease complexity and multimorbidity (next generation phenotyping and diagnostics, next generation therapeutics).
Read moreFor Arthritis Digest magazine, Dr Jenny Humphreys explains what is involved during the transition from adult to paediatric services for people with juvenile idiopathic arthritis.
Hearing loss is unlikely to be a common symptom of Covid-19, a study led by The University of Manchester and the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) scientists have shown.
There are plently of opportunities for people to help shape our research plans. Research is vital to help us understand more about a particular disease or condition and how to treat them.
Read more